Monica Schweickle and Chris Raine: Beyond the Trip: Can Psychedelics Change Mental Healthcare? Video
Beyond the Trip: A Psychedelic Therapy Podcast with Dr Esme DarkShow Notes
What happens when a radically different approach to mental health treatment meets an established healthcare system?
In this episode of Beyond the Trip, we explore what it really takes to bring psychedelic-assisted therapy into mainstream mental healthcare in Australia — from the therapy room to the systems and structures needed to support a new model of care.
I'm joined by Monica Schweickle, clinical psychologist and one of Australia's leading psychedelic-assisted therapists, and Chris Raine, mental health entrepreneur and co-founder of The Psychedelic Consultancy.
Monica was the first psychologist in the world to provide legal MDMA-assisted therapy to a client with PTSD outside of a clinical trial. With 20 years' experience working across trauma, veterans' mental health, domestic and family violence, government services and private practice, she brings a deeply clinical and practical perspective to the emerging field.
Chris brings a systems and innovation perspective. As the founder of Hello Sunday Morning and co-founder of Clean Slate Clinic, he has spent years developing new approaches to addiction and mental healthcare. As a 2024 Kenneth Myer Innovation Fellow, he also played a role in helping establish Australia's psychedelic-assisted therapy system and support access for its first 100 patients.
Together, we talk about the realities of building psychedelic therapy in Australia — what is working, what needs to change, and what we can learn as this field develops.
We explore:
• Their very different journeys into psychedelic therapy • What it takes to work within — and change — the Australian mental health system • The role of consultancy in supporting the emerging psychedelic therapy sector • Different therapeutic modalities and approaches to psychedelic-assisted psychotherapy • The potential role of psychedelic therapies in reducing reliance on antidepressant medication • The emerging Maudsley guidelines and what they mean for practice • The hopes, challenges and risks of bringing psychedelic therapy into mainstream care
And ultimately, we ask: Are psychedelics simply giving us another treatment option — or could they invite us to rethink mental healthcare altogether?
This is a conversation about clinical practice, systems change, innovation and the future of mental health care in Australia.
More from Beyond the Trip: A Psychedelic Therapy Podcast with Dr Esme Dark
In this episode of Beyond the Trip, I'm joined by Associate Professor Vanessa Beesley, a behavioural scientist and Team Head of the Psychedelic Medicine and Supportive Care Group at QIMR Berghofer Medical Research Institute, to explore the intersection of grief, psychedelic-assisted therapy and supportive care.
In this episode, I'm joined by Pedram Dara, founder and director of Psychedelic Lived Experiences, a global patient-led initiative working to bring lived experience into the heart of psychedelic research, clinical practice, and policy.
Welcome to Part 2 of my interview series with Dr Marg Ross, clinical psychologist and Chief Principal Investigator of Australia's first psychedelic-assisted therapy trial exploring psilocybin for end-of-life distress.
Beyond the Trip is delighted to be collaborating with Kyle Buller from Psychedelics Today for this episode, where we discuss many topics, including
In this episode of Beyond the Trip, we're joined by Dr Marg Ross, clinical psychologist and Chief Principal Investigator of Australia's first psychedelic-assisted therapy trial exploring the use of psilocybin for end-of-life distress.